Correlation Between Biotechnology Ultrasector and Capital World

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Capital World at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Capital World into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Capital World Bond, you can compare the effects of market volatilities on Biotechnology Ultrasector and Capital World and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Capital World. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Capital World.

Diversification Opportunities for Biotechnology Ultrasector and Capital World

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biotechnology and Capital is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Capital World Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capital World Bond and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Capital World. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capital World Bond has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Capital World go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Capital World

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Capital World. In addition to that, Biotechnology Ultrasector is 5.87 times more volatile than Capital World Bond. It trades about -0.06 of its total potential returns per unit of risk. Capital World Bond is currently generating about 0.17 per unit of volatility. If you would invest  1,539  in Capital World Bond on December 2, 2024 and sell it today you would earn a total of  37.00  from holding Capital World Bond or generate 2.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Capital World Bond

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Capital World Bond 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Capital World Bond has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental drivers, Capital World is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector and Capital World Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Capital World

The main advantage of trading using opposite Biotechnology Ultrasector and Capital World positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Capital World can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capital World will offset losses from the drop in Capital World's long position.
The idea behind Biotechnology Ultrasector Profund and Capital World Bond pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities